L’ÉLEVAGE DE SINGES À MAURICE

Au Cœur des Progrès Médicaux Mondiaux

L’ÉLEVAGE DE SINGES À MAURICE

Au Cœur des Progrès Médicaux Mondiaux

 

“By creating a viable biotech sector, we can retain our talent,” Dr Rattan Gujadhur, Biotechnology Head in the U.S.
“Mauritius can be a credible site for advanced preclinical/clinical research”
“Hosting key clinical trials would allow local patients access to innovative therapies.”
“Other economies like Rwanda, Botswana, Kenya, Nigeria and many others in the Africa east/west clusters are getting serious about biotech. We must catch up.”
“During the legislative discussions at MIBL, one of the main recommendations was to establish a healthcare authority in Mauritius—a regulatory body similar in function to the U.S. FDA.”
“The reasoning was simple: there’s a potential conflict of interest if the same ministry is responsible for both developing the health sector and approving drugs.”
“I genuinely want to see my country grow. I want to see Mauritians return home to create value. But time is moving quickly.”